These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

857 related articles for article (PubMed ID: 7680959)

  • 1. SH2 domains recognize specific phosphopeptide sequences.
    Songyang Z; Shoelson SE; Chaudhuri M; Gish G; Pawson T; Haser WG; King F; Roberts T; Ratnofsky S; Lechleider RJ
    Cell; 1993 Mar; 72(5):767-78. PubMed ID: 7680959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav.
    Songyang Z; Shoelson SE; McGlade J; Olivier P; Pawson T; Bustelo XR; Barbacid M; Sabe H; Hanafusa H; Yi T
    Mol Cell Biol; 1994 Apr; 14(4):2777-85. PubMed ID: 7511210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
    Bibbins KB; Boeuf H; Varmus HE
    Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of peptide molecular recognition by phospholipase C gamma-1 Src homology-2 domain and a mutant Tyr phosphatase PTP1bC215S.
    MacLean D; Sefler AM; Zhu G; Decker SJ; Saltiel AR; Singh J; McNamara D; Dobrusin EM; Sawyer TK
    Protein Sci; 1995 Jan; 4(1):13-20. PubMed ID: 7773170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heteronuclear NMR studies of the combined Src homology domains 2 and 3 of pp60 c-Src: effects of phosphopeptide binding.
    Tessari M; Gentile LN; Taylor SJ; Shalloway DI; Nicholson LK; Vuister GW
    Biochemistry; 1997 Nov; 36(47):14561-71. PubMed ID: 9398174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphopeptide-binding specificity of Src family SH2 domains.
    Payne G; Stolz LA; Pei D; Band H; Shoelson SE; Walsh CT
    Chem Biol; 1994 Oct; 1(2):99-105. PubMed ID: 9383377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.
    Nam NH; Ye G; Sun G; Parang K
    J Med Chem; 2004 Jun; 47(12):3131-41. PubMed ID: 15163193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction and analysis of SH2 domain-phosphopeptide interactions.
    Zvelebil MJ; Panayotou G; Linacre J; Waterfield MD
    Protein Eng; 1995 Jun; 8(6):527-33. PubMed ID: 8532676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.
    Ladbury JE; Lemmon MA; Zhou M; Green J; Botfield MC; Schlessinger J
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3199-203. PubMed ID: 7536927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence, structure and energetic determinants of phosphopeptide selectivity of SH2 domains.
    Sheinerman FB; Al-Lazikani B; Honig B
    J Mol Biol; 2003 Dec; 334(4):823-41. PubMed ID: 14636606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity.
    Shakespeare W; Yang M; Bohacek R; Cerasoli F; Stebbins K; Sundaramoorthi R; Azimioara M; Vu C; Pradeepan S; Metcalf C; Haraldson C; Merry T; Dalgarno D; Narula S; Hatada M; Lu X; van Schravendijk MR; Adams S; Violette S; Smith J; Guan W; Bartlett C; Herson J; Iuliucci J; Weigele M; Sawyer T
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9373-8. PubMed ID: 10944210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide.
    Pascal SM; Singer AU; Gish G; Yamazaki T; Shoelson SE; Pawson T; Kay LE; Forman-Kay JD
    Cell; 1994 May; 77(3):461-72. PubMed ID: 8181064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes.
    Nolte RT; Eck MJ; Schlessinger J; Shoelson SE; Harrison SC
    Nat Struct Biol; 1996 Apr; 3(4):364-74. PubMed ID: 8599763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific stimulation of c-Fgr kinase by tyrosine-phosphorylated (poly)peptides--possible implication in the sequential mode of protein phosphorylation.
    Ruzzene M; Brunati AM; Donella-Deana A; Marin O; Pinna LA
    Eur J Biochem; 1997 May; 245(3):701-7. PubMed ID: 9183008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.
    Domchek SM; Auger KR; Chatterjee S; Burke TR; Shoelson SE
    Biochemistry; 1992 Oct; 31(41):9865-70. PubMed ID: 1382595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative self-assembly of SH2 domain fragments restores phosphopeptide binding.
    Williams KP; Shoelson SE
    Biochemistry; 1993 Oct; 32(42):11279-84. PubMed ID: 7692962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.